What is Microbiosensor?
Microbiosensor Ltd. operates at the intersection of biotechnology and clinical diagnostics, focusing on the development of rapid, point-of-care devices. The company utilizes proprietary chemical reagents to facilitate the detection of bacterial infections through intuitive color-change mechanisms. By providing early warning systems for microbial presence, the firm enables healthcare practitioners to assess leukocyte levels and antibiotic sensitivities with unprecedented speed. This technology serves as a critical adjunct to traditional laboratory workflows, directly addressing the global challenge of antimicrobial resistance and enhancing clinical outcomes for patients undergoing complex treatments such as peritoneal dialysis.
How much funding has Microbiosensor raised?
Microbiosensor has raised a total of $920K across 1 funding round:
Private Equity
$920K
Private Equity (2017): $920K with participation from Northern Powerhouse Investment Fund
Key Investors in Microbiosensor
Northern Powerhouse Investment Fund
A regional investment initiative focused on boosting local economic growth through strategic backing of innovation, skills, and infrastructure development.
What's next for Microbiosensor?
With this major enterprise-level funding, Microbiosensor is poised to scale its manufacturing capabilities and expand its clinical validation studies. The strategic roadmap likely involves deepening market penetration within specialized medical sectors where rapid diagnostic turnaround is essential for patient safety. As the firm moves beyond its initial development phase, the focus will shift toward regulatory scaling and the integration of its diagnostic platforms into broader hospital information systems, ensuring that their early-warning technology becomes a standard component of modern infection control protocols.
See full Microbiosensor company page
